Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus

BackgroundDiabetic nephropathy is a leading cause of end-stage renal disease. The diagnostic markers of nephropathy, including the presence of albuminuria and/or a reduced estimated glomerular filtration rate, are not clinically ideal, and most of them are raised after a significant reduction in ren...

詳細記述

書誌詳細

主要な著者:	Tadesse Asmamaw Dejenie, Endeshaw Chekol Abebe, Misganaw Asmamaw Mengstie, Mohammed Abdu Seid, Natnael Atnafu Gebeyehu, Getachew Asmare Adella, Gizchew Ambaw Kassie, Amanuel Yosef Gebrekidan, Molalegn Mesele Gesese, Kirubel Dagnaw Tegegne, Denekew Tenaw Anley, Sefineh Fenta Feleke, Melkamu Aderajew Zemene, Anteneh Mengist Dessie, Natnael Moges, Yenealem Solomon Kebede, Berihun Bantie, Dagnew Getnet Adugna
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2023-04-01
シリーズ:	Frontiers in Endocrinology
主題:	diabetes diabetic nephropathy serum cystatin C serum creatinine dyslipidemia
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1124367/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!